Error loading player: No playable sources found

2185

Kiron and Kamala Das Symposium — Precision Medicine in IBD: The Road Ahead

Date
May 18, 2024

SOCIETY: AGA With the expansion of IBD treatment options, there is increasingly the need for predictive models to determine which treatments work best for which patients with IBD.

Presentations:

PROGNOSTICATION OF DISEASE COURSE IN IBD: THE PRESENT AND THE FUTURE
CAN CLINICAL PHENOTYPES AID IN PICKING THE RIGHT THERAPY FOR YOUR PATIENT?
STATISTICAL METHODS FOR THERAPEUTIC SEQUENCING: META-ANALYSES AND NETWORK META-ANALYSES
THE EMERGING ROLE OF MULTI-OMICS IN PERSONALIZING IBD THERAPY
PANEL DISCUSSION

Moderators

Speaker Image for Lee Denson
Cincinnati Children’s Hospital Medical Center
Speaker Image for Dermot P.B. Mcgovern
Cedars-Sinai Medical Center

Speakers

Speaker Image for Séverine Vermeire
Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven
Speaker Image for Parambir Dulai
Northwestern University Feinberg School of Medicine
Speaker Image for Siddharth Singh
Speaker Image for Bram Verstockt
University Hospitals Leuven

Related Products

Thumbnail for AGA Application of Omics to Predict Disease Course and Treatment Outcomes in IBD
Thumbnail for Insights into IBD Biology From Single-Cell Sequencing
Insights into IBD Biology From Single-Cell Sequencing
(WITHDRAWN) SINGLE CELL ANALYSIS OF GUT BIOPSY TISSUE REVEALS CELL TYPE- AND INFLAMMATION-SPECIFIC EXPRESSION QUANTATIVE TRAIT LOCI IN CROHN'S DISEASE
Thumbnail for PANEL DISCUSSION
Thumbnail for AGA The Mucosal Immune Response and Nonimmune Cells in IBD
AGA The Mucosal Immune Response and Nonimmune Cells in IBD
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…